Levent SENNAROĞLU, Betül Çiçek ÇINAR, Gamze ATAY, Sarp SARAÇ, Bahar KAYAHAN

Prognostic Factors in Sudden Sensorineural Hearing Loss

Background:Suddensensorineuralhearingloss(SSNHL) is still a complex and challenging process which requires clinical evidence regarding its etiology, treatment and prognostic factors. Therefore, determina-tion of prognostic factors might aid in the selection of proper treatment modality. Aims: The aim of this study is to analyze whether there is correlation between SSNHL outcomes and (1) sys-temic steroid therapy, (2) time gap between onset of symptoms and initiation of therapy and (3) audiological pattern of hearing loss. Study Design: Retrospective chart review.Methods: Patients diagnosed at our clinic with SSNHL between May 2005 and December 2011were reviewed. A detailed history of demographic features, side of hear-ing loss, previous SSNHL and/or ear surgery, recent up-per respiratory tract infection, season of admission, du-ration of symptoms before admission and the presence of co-morbid diseases was obtained. Radiological and audiological evaluations were recorded and treatment protocol was assessed to determine whether systemic steroids were administered or not. Treatment started 5 days as "de-layed". Initial audiological configurations were grouped as "upward sloping", "downward sloping", "flat" and "profound" hearing loss. Significant recovery was de-fined as thresholds improved to the same level with the unaffected ear or improved >=30 dB on average. Slight recovery was hearing improvement between 10-30dB on average. Hearing recovery less than 10 dB was ac-cepted as unchanged. Results: Among the 181 patients who met the inclusion criteria, systemic steroid was administered to 122 pa-tients (67.4%), whereas 59 (32.6%) patients did not have steroids. It was found that steroid administration did not have any statistically significant effect in either recov-ered or unchanged hearing groups. Early treatment was achieved in 105 patients (58%) and 76 patients (42%) had delayed treatment. Recovery rates were no different in these two groups; however, when unchanged hearing rates were compared, it was statistically significantly lower in the early treatment group(p

PDF

___

Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al: American Academy of Otolaryngology-Head and Neck Surgery. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(Suppl 3):S1-35.
Wilson WR, Byl MF, Laird N. The Efficacy of Steroids in the Treatment of Idiopathic Sudden Hearing Loss A Double-blind Clinical Study, Arch Otolaryngol 1980;106:772-6.
Castro TM, Costa LA, Nemezio ME, Fonseca LJ. Bilateral sud- den deafness. Braz J Otorhinolaryngol 2011;77:678.
Spear SA, Schwartz SR. Intratympanic steroids for sudden sen- sorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534-43.
Liu SC, Kang BH, Lee JC, Lin YS, Huang KL, Liu DW, et al. Comparison of therapeutic results in sudden sensorineural hear- ing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clin Otolaryngol 2011;36:121-8.
Coelho DH, Thacker LR, Hsu DW. Variability in the manage ment of idiopathic sudden sensorineural hearing loss. Otolaryn- gol Head Neck Surg 2011;145:813-7.
Piccirillo JF. Steroids for idiopathic sudden sensorineural hearing loss: some questions answered, others remain. JAMA 2011;305:2114-5.
Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011;15:91-105.
Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idio- pathic sudden sensorineural hearing loss cases. Eur Arch Otorhi- nolaryngol 2011;268:1735-41.
Jun HJ, Chang J, Im GJ, Kwon SY, Jung H, Choi J. Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss. Acta Otolaryngol 2012;132:590-6.
Suckfüll M. Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss. Dtsch Arztebl Int 2009;106:669-75.
Narozny W, Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mi kaszewski B. Prognostic factors in sudden sensorineural hear- ing loss: our experience and a review of the literature. Ann Otol Rhinol Laryngol 2006;115:553-8.
Ceylan A, Celenk F, Kemaloğlu YK, Bayazit YA, Göksu N, Ozbilen S. Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol 2007;121:1035-40.
Cadoni G, Agostino S, Scipione S, Ippolito S, Caselli A, Marchese R, et al. Sudden sensorineural hearing loss: our experi- ence in diagnosis, treatment, and outcome. J Otolaryngol 2005;34:395-401.
Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 2003;128:92-8.
Saeki N, Kitahara M. Assessment of prognosis in sudden deafness. Acta Otolaryngol Suppl 1994;510:56-6.
Lin SW, Lin YS, Weng SF. Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based co- hort study. Otol Neurotol 2012;33:1482-8.
Chien CY, Tai SY, Wang LF, Hsi E, Chang NC, Wu MT, et al. Metabolic syndrome increases the risk of sudden sensorineural hearing loss in Taiwan: a case-control study. Otolaryngol Head Neck Surg 2015;153:105-11.
Plaza G, Durio E, Herráiz C, Rivera T, García-Berrocal JR; Asociación Madrileña de ORL. Consensus on diagnosis and treatment of sudden hearing loss. Acta Otorrinolaringol Esp 2011;62:144-57.
Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 2007;133:573-81.
Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 2007;133:582-6.
Kanemaru S, Fukushima H, Nakamura H, Tamaki H, Fukuyama Y, Tamura Y. Alpha-Interferon for the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 1997;254:158-62.
Fu Y, Zhao H, Zhang T, Chi F. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation. Auris Nasus Larynx 2011;38:165-71.
Park KH, Lee CK, Lee JD, Park MK, Lee BD. Combination therapy with systemic steroids, an antiviral agent, anticoagu- lants, and stellate ganglion block for treatment of sudden senso- rineural hearing loss. Korean J Audiol 2012;16:71-4.
Chang NC, Ho KY, Kuo WR. Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolaryngol Head Neck Surg 2005;133:916-22.
Mamak A, Yilmaz S, Cansiz H, İnci E, Güçlü E, Dereköylü L. A study of prognostic factors in sudden hearing loss. Ear Nose Throat J 2005;84:641-4.
Banerjee A, Parnes LS. Intratympanic corticosteroids forsudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878-81.
Belhassen S, Saliba I. Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss. J Laryngol Otol 2014;128:1044-9.